Effects of Blackberry-derived Polyphenols on Cardiovascular Risk in Adults
Launched by UNIVERSITY COLLEGE CORK · Jan 30, 2015
Trial Information
Current as of October 27, 2025
Completed
Keywords
ClinConnect Summary
Dietary factors play a significant role in the prevention and/or treatment of hypertension and significant efforts are being put in to the development of functional foods with antihypertensive activity. Blackberries and their intrinsic polyphenols, consumed as part of a healthy diet, may be of functional interest in both the treatment and prevention of hypertension and dyslipidaemia. The Cardio-Rubus study presents healthy adults with an opportunity to participate in a human nutrition study that will assist in identifying biological effects of blackberry-derived components establishing furt...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult Caucasian men and women (ratio men: women, 70:30)
- • Good general health
- • Systolic blood pressure: 130 - 149 mmHg
- • Body mass index (BMI): 25.0 - 35.0 kg/m2
- • Signed consent form
- Exclusion Criteria:
- • Current smokers
- • Diagnosed hypertension
- • History of cardiovascular events such as stroke, myocardial infarction or peripheral vascular disease
- • Diagnosed medical illness including diabetes mellitus (Types 1 \& 2), chronic kidney disease and gastro-intestinal diseases
- • Medications that may affect any of the study outcome measures: anti-hypertensive medications and lipid lowering therapies e.g. statins.
- • Suspected hypersensitivity or allergy to berries.
- • Intolerance for aspirin or salicylate acid.
- • Current consumption of nutraceuticals, botanical extracts or other polyphenol-rich supplements.
About University College Cork
University College Cork (UCC) is a leading research institution located in Ireland, renowned for its commitment to advancing healthcare through innovative clinical research. The university's clinical trial unit is dedicated to conducting high-quality, ethically sound studies that aim to improve patient outcomes and contribute to the scientific understanding of various medical conditions. UCC collaborates with a diverse network of healthcare professionals, researchers, and industry partners to facilitate pioneering trials across multiple therapeutic areas, ensuring adherence to the highest standards of regulatory compliance and patient safety. Through its initiatives, UCC strives to foster advancements in medicine and enhance the overall health of communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cork, Ireland
Patients applied
Trial Officials
Mairead Kiely, PhD
Principal Investigator
School of Food & Nutritional Sciences, University College Cork.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials